Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 8/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 7/20 | 0.42 |
| ▸ | SIRT5 | Q9NXA8 | 3/20 | 0.41 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPY1R | P25929 | 1/20 | 0.38 |
| ▸ | NPY2R | P49146 | 1/20 | 0.38 |
| ▸ | NPY4R | P50391 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.38 |
| ▸ | FURIN | P09958 | 2/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19709072 | 1.00 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT | |
| SCHEMBL17722898 | 1.00 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT | |
| SCHEMBL17815262 | 1.00 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT | |
| SCHEMBL21008362 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT | |
| SCHEMBL21413563 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT | |
| SCHEMBL20467873 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT | |
| SCHEMBL26412865 | 0.94 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT | |
| SCHEMBL17722938 | 0.93 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT | |
| SCHEMBL19046498 | 0.93 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT | |
| SCHEMBL17815409 | 0.93 | SIRT2 (0.42) | SIRT2SIRT1SIRT5SIRT3HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3835322-A2 | ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES | AbbVie Inc. (US) | 2021-06-16 | — | — | EP | disclosed |
| EP-3735990-A1 | ANTIBODY DRUG CONJUGATES WITH CELL PERMEABLE BCL-XL INHIBITORS | Abbvie Inc. (US) | 2020-11-11 | — | — | EP | disclosed |
| EP-3229844-B1 | ANTIBODY DRUG CONJUGATES WITH CELL PERMEABLE BCL-XL INHIBITORS | ABBVIE INC (US) | 2020-03-04 | — | — | EP | disclosed |